Blood Viscosity During Long-Term Treatment with Ticlopidine in Patients with Intermittent Claudication. A Double-Blind Study

Angiology ◽  
1993 ◽  
Vol 44 (4) ◽  
pp. 300-306 ◽  
Author(s):  
Birger Fagher ◽  
Sylvi Persson ◽  
Gunnar Persson ◽  
Hans Larsson
Keyword(s):  
Intermittent Claudication ◽  
Blood Viscosity ◽  
Term Treatment ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Long Term Treatment

A Double-Blind Study of Long-Term Treatment With Sertraline or Fluvoxamine for Prevention of Highly Recurrent Unipolar Depression

1997 ◽  
Vol 58 (3) ◽  
pp. 104-107 ◽  
Author(s):  
Linda Franchini ◽  
Mariangela Gasperini ◽  
Jorge Perez ◽  
Enrico Smeraldi ◽  
Raffaella Zanardi
Keyword(s):  
Unipolar Depression ◽  
Term Treatment ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Long Term Treatment

Results of a Double-Blind Study with Adalat under Short- and Long-Term Treatment

1975 ◽  
pp. 333-340
Author(s):  
J. Menna ◽  
M. Traina ◽  
J. C. Cassera ◽  
E. Ferreirós ◽  
R. Rohwedder
Keyword(s):  
Term Treatment ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Long Term Treatment ◽  
Short And Long Term

Results of a Double-Blind Study with Adalat under Short- and Long-Term Treatment

1975 ◽  
pp. 333-340
Author(s):  
J. Menna ◽  
M. Traina ◽  
J. C. Cassera ◽  
E. Ferreirós ◽  
R. Rohwedder
Keyword(s):  
Term Treatment ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Long Term Treatment ◽  
Short And Long Term

scholarly journals Venlafaxine Extended Release (ER) in the Treatment of Generalised Anxiety Disorder

2001 ◽  
Vol 179 (1) ◽  
pp. 15-22 ◽  
Author(s):  
Christer Allgulander ◽  
David Hackett ◽  
Eliseo Salinas
Keyword(s):  
Anxiety Disorder ◽  
Extended Release ◽  
Term Treatment ◽  
Double Blind Study ◽  
Generalised Anxiety Disorder ◽  
Double Blind ◽  
Treatment Groups ◽  
Long Term Treatment ◽  
Higher Doses

BackgroundGeneralised anxiety disorder (GAD) has received less study than other anxiety disorders, particularly its long-term treatment.AimsTo assess the efficacy and safety of venlafaxine extended release (ER) in patients with GAD.MethodA total of 541 out-patients, 18–86 years old, were recruited to this 24-week, placebo-controlled, double-blind study of three fixed doses (37.5, 75 and 150 mg/day) of venlafaxine ER.ResultsAll doses of venlafaxine ER showed efficacy superior to placebo, apparent from week 2, that was sustained throughout the 24-week study for the two higher doses. The discontinuation rate did not differ significantly among the treatment groups.ConclusionsVenlafaxine ER is an effective and safe treatment for GAD for up to 6 months.

A Multicenter, Randomized, Double-Blind Study Comparing a Daily Bedtime Administration of Famotidine and Ranitidine in Short-Term Treatment of Active Duodenal Ulcer

Digestion ◽  
1989 ◽  
Vol 42 (2) ◽  
pp. 79-85 ◽  
Author(s):  
R. Alcalá-Santaella ◽  
J. Guardia ◽  
J. Pajares ◽  
J. Piqué ◽  
L. Pita ◽  
...  
Keyword(s):  
Duodenal Ulcer ◽  
Term Treatment ◽  
Blind Study ◽  
Double Blind Study ◽  
Short Term ◽  
Short Term Treatment ◽  
Double Blind
Sign in / Sign up

Export Citation Format

Share Document